Skip to Main Content

Lyell Immunopharma

Lyell Immunopharma develops advanced CAR T-cell therapies for cancer treatment, concentrating on both hematologic malignancies and solid tumors through innovative T-cell reprogramming techniques.

Site Profile
Security Setup
CMissing 4 of 7 security checks
  • No HSTS
  • No X-Frame-Options
  • No X-Content-Type
  • No Referrer-Policy

Passing

SSL certificate · HTTPS enforced · TLS 1.3

Not Set

Content-Security-Policy · Permissions-Policy

Last scanned

Lyell-Immunopharma Homepage 1440px